Giandomenico Maggiore

17PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCharacterisation of biological macromoleculesMedical devicesNanomedicineRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Apr 23, 2025
Sustained Efficacy and Low Rate of Adverse Events of Dupilumab in Type-2 CRSwNP Over 48 Months.

Pietro Orlando, Giuseppe Licci, Gennaro Illiano

|Nov 14, 2024
In Reference to Predictors of Sinonasal Improvement After Highly Effective Modulator Therapy in Adults with Cystic Fibrosis.

Alberto Minzoni, Pietro Orlando, Giandomenico Maggiore

|Oct 15, 2024
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study.

Pietro Orlando, Emanuele Vivarelli, Alberto Minzoni

|Nov 01, 2023
Effectiveness of dupilumab versus endoscopic sinus surgery for the treatment of type-2 chronic rhinosinusitis with nasal polyps: a preliminary report.

Pietro Orlando, Giuseppe Licci, Donald Kuitche

|Aug 12, 2023
Radiomics-Based Analysis in the Prediction of Occult Lymph Node Metastases in Patients with Oral Cancer: A Systematic Review.

Serena Jiang, Luca Giovanni Locatello, Giandomenico Maggiore

Pageof 3